Literature DB >> 3875453

Morphologic changes in long-term saphenous vein bypass grafts.

J B Atkinson, M B Forman, W K Vaughn, M Robinowitz, H A McAllister, R Virmani.   

Abstract

A retrospective autopsy study was performed in 56 patients who had undergone saphenous vein bypass graft (SVBG) surgery 12 to 168 months prior to death. Twenty-five grafts had atherosclerosis, 66 grafts had fibrointimal proliferation, and 26 grafts were fibrotic with total occlusion. No significant differences were noted among the three morphologic groups with regard to age of the patient or number of native coronary arteries severely narrowed. Vein grafts with fibrointimal proliferation occurred with greater frequency in patients with systemic hypertension (p less than 0.001), and atherosclerotic grafts were more prevalent in patients with hypercholesterolemia (p less than 0.02). Therefore, the presence of risk factors may determine the type of change that occurs in saphenous vein bypass grafts: systemic hypertension leads to fibrointimal proliferation, whereas hypercholesterolemia leads to atherosclerotic change.

Entities:  

Mesh:

Year:  1985        PMID: 3875453     DOI: 10.1378/chest.88.3.341

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Inhibition of vein graft intimal proliferative lesions in the rat by heparin.

Authors:  G M Hirsch; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

2.  Why is the mammary artery so special and what protects it from atherosclerosis?

Authors:  Fumiyuki Otsuka; Kazuyuki Yahagi; Kenichi Sakakura; Renu Virmani
Journal:  Ann Cardiothorac Surg       Date:  2013-07

3.  Autogenous artery grafts in hypertensive (SHR) rats do not have increased smooth muscle cell hyperplasia in the graft neointima, compared with grafts in normotensive rats.

Authors:  A J Redwood; S Moore; L Sayadelmi; M Tennant
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

4.  Endothelin receptor expression and pharmacology in human saphenous vein graft.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Intraluminal thrombosis of coronary arteries in fatal myocardial infarctions and in failed aortocoronary saphenous vein grafts.

Authors:  W H Kern
Journal:  West J Med       Date:  1988-10

6.  Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.

Authors:  L A Pukac; G M Hirsch; J C Lormeau; M Petitou; J Choay; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

7.  Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats.

Authors:  Nick D Tsihlis; Ashley K Vavra; Janet Martinez; Vanessa R Lee; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2013-10-19       Impact factor: 4.427

Review 8.  Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.

Authors:  Kazuyuki Yahagi; Frank D Kolodgie; Fumiyuki Otsuka; Aloke V Finn; Harry R Davis; Michael Joner; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2015-10-27       Impact factor: 32.419

Review 9.  Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound.

Authors:  Gavin J Murphy; Gianni D Angelini
Journal:  Cardiovasc Ultrasound       Date:  2004-07-21       Impact factor: 2.062

Review 10.  Rapid Progression of Coronary Atherosclerosis: A Review.

Authors:  Priyank Shah; Sharad Bajaj; Hartaj Virk; Mahesh Bikkina; Fayez Shamoon
Journal:  Thrombosis       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.